购物车
- 全部删除
- 您的购物车当前为空
SRI 37892是一种 Fzd7抑制剂,对 Wnt/β-catenin 信号传导和癌症细胞活性具有强大的活性。
为众多的药物研发团队赋能,
让新药发现更简单!
SRI 37892是一种 Fzd7抑制剂,对 Wnt/β-catenin 信号传导和癌症细胞活性具有强大的活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,960 | 现货 | |
5 mg | ¥ 6,860 | 现货 | |
10 mg | ¥ 9,430 | 现货 | |
25 mg | ¥ 13,800 | 现货 | |
50 mg | ¥ 18,900 | 现货 | |
100 mg | ¥ 25,500 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 7,630 | 现货 |
产品描述 | SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell viability. |
体外活性 | SRI37892 block Wnt/β-catenin signaling in HEK293 cells induced by Wnt3A and LRP6 with IC50 of 0.66 μM and 0.78 μM, respectively[1]. |
分子量 | 465.53 |
分子式 | C26H19N5O2S |
CAS No. | 1030769-75-5 |
Smiles | C(NC1=NC(=CS1)C=2C=C3C(=CC2)NC(=O)CC3)(=O)C4=CC=C(N5C=6C(N=C5)=CC=CC6)C=C4 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (107.4 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容